
Curevo Vaccine
Developer of a clinical-stage adjuvanted subunit vaccine intended to improve efficacy and broaden immune response. The company leverages its proprietary platform to design and develop vaccines that ta...
Valuation
$0
Share Price
N/A
Total Raised
$206.2M
Last Round
N/A